Insulin resistance and heart failure during treatment with sodium glucose cotransporter 2 inhibitors: proposed role of ketone utilization

Y Hattori - Heart Failure Reviews, 2020 - Springer
Abstract Sodium glucose cotransporter 2 (SGLT2) inhibitors reduce the rate of
hospitalization for heart failure in individuals with type 2 diabetes, but the underlying …

Insulin resistance and heart failure during treatment with sodium glucose cotransporter 2 inhibitors: proposed role of ketone utilization

Y Hattori - Heart failure reviews, 2020 - pubmed.ncbi.nlm.nih.gov
Sodium glucose cotransporter 2 (SGLT2) inhibitors reduce the rate of hospitalization for
heart failure in individuals with type 2 diabetes, but the underlying mechanisms remain …

Insulin resistance and heart failure during treatment with sodium glucose cotransporter 2 inhibitors: proposed role of ketone utilization

H Yoshiyuki - Heart Failure Reviews, 2020 - search.proquest.com
Abstract Sodium glucose cotransporter 2 (SGLT2) inhibitors reduce the rate of
hospitalization for heart failure in individuals with type 2 diabetes, but the underlying …

Insulin resistance and heart failure during treatment with sodium glucose cotransporter 2 inhibitors: proposed role of ketone utilization.

Y Hattori - Heart Failure Reviews, 2020 - europepmc.org
Sodium glucose cotransporter 2 (SGLT2) inhibitors reduce the rate of hospitalization for
heart failure in individuals with type 2 diabetes, but the underlying mechanisms remain …

[引用][C] Insulin resistance and heart failure during treatment with sodium glucose cotransporter 2 inhibitors: proposed role of ketone utilization

Y Hattori - Heart Failure Reviews, 2020 - cir.nii.ac.jp
Insulin resistance and heart failure during treatment with sodium glucose cotransporter 2
inhibitors: proposed role of ketone utilization | CiNii Research CiNii 国立情報学研究所 学術 …